| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.64B | $1.28B | $965.8M |
| YoY Revenue Growth % | +27.9% | +32.6% | — |
| Gross Profit | $423.9M | $340.1M | — |
| Gross Margin % | 25.9% | 26.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $161.2M | $106.1M | $46.2M |
| Operating Margin % | 9.8% | 8.3% | 4.8% |
| Net Income (GAAP) | $79.8M | $35.3M | $1.7M |
| EBITDA (Normalized) | $354.1M | $283.5M | $81.0M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $295.5M | $246.4M | $139.9M |
| Capital Expenditures (CapEx) | $241.1M | $221.7M | $43.5M |
| Free Cash Flow (FCF) | $54.4M | $24.7M | $96.5M |
| FCF Margin % | 3.3% | 1.9% | 10.0% |
| Return on Invested Capital (ROIC %) | 21.0% | 18.1% | 1.4% |
| Cash & Short-Term Equivalents | $269.4M | $293.4M | — |
| Total Debt (Short + Long Term) | $196.3M | $219.8M | $988.7M |
| Total Stockholders' Equity | $680.8M | $537.4M | $2.03B |